Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification

by Edward C Lauterbach
Published 2016-01-01

Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease

by Edward C. Lauterbach
Published 2013-11-01

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease

by Edward C. Lauterbach, Leonardo F. Fontenelle, Antonio L. Teixeira
Published 2012-01-01

Neuropsychiatry of Parkinson's Disease

by Antonio L. Teixeira, Leonardo F. Fontenelle, Edward C. Lauterbach, Sergio Starkstein
Published 2012-01-01

Revisiting the neuropsychiatry of Huntington's disease

by Antonio Lucio Teixeira, Leonardo Cruz de Souza, Natalia Pessoa Rocha, Erin Furr-Stimming, Edward C. Lauterbach

Psychopathological evaluation and use of the Hospital Anxiety and Depression Scale in a sample of Brazilian patients with post-stroke depression

by Vinicius S. P. Pedroso, Érica L. M. Vieira, André R. Brunoni, Edward C. Lauterbach, Antônio L. Teixeira

Early psychiatric morbidity in a Brazilian sample of acute ischemic stroke patients

by Vinicius S.P. Pedroso, Andre R. Brunoni, Érica L.M. Vieira, Ricardo E. Jorge, Edward C. Lauterbach, Antonio L. Teixeira
Published 2018-05-01